Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip to main content
Donate

Let's beat cancer sooner

Citizen Science: “you don’t need to be qualified to do this”

Category: Science Blog October 3, 2014

To mark the launch of our latest Citizen Science game, Reverse The Odds, we caught up with one the researchers that you’ll be helping by playing the game.

Read More

Accelerating new treatments – our Centre for Drug Development

Category: Science Blog September 29, 2014

Something extraordinary is happening right now. Impelled by the Ebola outbreak in West Africa, researchers, medics, funding agencies, pharmaceutical companies a...

Read More

Classifying leukaemia: one size doesn’t fit all

Category: Science Blog September 26, 2014

This entry is part 18 of 19 in the series Our milestones

A landmark research paper in 1977 changed the way children with acute leukaemia are diagnosed and treated. We look at the story of a research milestone.

Read More

The Cancer Patient Experience Survey – questions have been asked…now what?

Category: Science Blog September 25, 2014

It may seem as though we’re constantly asked to give feedback – but what’s more important is knowing what’s happened as a result of our comments –...

Read More

Saving lives and averting costs? The case for earlier diagnosis just got stronger

Category: Science Blog September 22, 2014

A guest post from Incisive Health’s Mike Birtwhistle, who has just produced a new report for Cancer Research UK on the economic impact of early diagnosis.

Read More

The big issues affecting lung cancer worldwide

Category: Science Blog September 11, 2014

We’ve teamed up with the journal Nature, which today publishes a series of articles that touch on some key areas for lung cancer from across the globe.

Read More

Prostate cancer: researchers begin to unpick drug resistance

Category: Science Blog September 5, 2014

A look at some recent findings from the US, from researchers studying how prostate cancers can be resistant to two new drugs – abiraterone and enzalutamide

Read More